Company / AR per Share
Catalyst Pharmaceuticals Partners, Inc. AR per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$1.03
FY2025
5-year range
$0.06 / $1.03
FY2021-FY2025
Trend
+90.6%
vs FY2024
Sector context
#50 of 112
Health Care
What the data says
At $1.03, Catalyst Pharmaceuticals Partners, Inc.'s ar per share ranks #50 of 112 in the Health Care sector. AR per Share has increased for 5 consecutive years, from $0.06 in FY2020 to $1.03 in FY2025.
Based on SEC 10-K filings.
1.03 in FY2025 with a 5-year CAGR of +77.9%.
Improved from $0.50 to $1.03 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- +118.3%
- 5-Year CAGR
- +77.9%
- 10-Year CAGR
- -
Sector benchmark
#50 of 112 in Health CareTop 45% of 112This company $1.03 Sector average $29.00
▼
-96.4% below sector average
Key checks
Key Insights
- Catalyst Pharmaceuticals Partners, Inc.'s ar per share has grown for 5 consecutive years.
- In FY2025, ar per share increased 90.6% year-over-year.
- Ranks #50 out of 112 companies in the Health Care sector.
- Lowest ar per share in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score 4.78 (safe zone, above 2.9 threshold)
- Strong profit margin: 33.3%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.03 | +90.6% |
| FY2024 | $0.54 | +8.4% |
| FY2023 | $0.50 | +403.7% |
| FY2022 | $0.10 | +54.3% |
| FY2021 | $0.06 | +11.0% |
| FY2020 | $0.06 | -43.5% |
| FY2019 | $0.10 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026